Clin2
NCT07081217Possibly a fitRecruiting

Testing a new pain drug called Radiocaine

Healthy Subjects

This study tests whether a new numbing medicine, called Radiocaine, is safe and works well for pain. You will have imaging scans and blood tests to see how the drug acts in your body.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
6 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must not weigh more than 300 pounds and your BMI must be under 32.
  • You must be willing to have blood tests, heart monitoring, and imaging scans.
  • You must be free of conditions like severe depression, anxiety, or a history of seizures.
  • You must not have had major surgery or taken certain heart or seizure medicines recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03427736Recruiting
Studying pain and numbing medicines in children

This trial looks at how well different numbing and pain-relief medicines work in children during routine care. It may help doctors choose safer, better pain control for kids who need these medicines.

Stanford, California
NCT05641948Recruiting
Tested nerve ablation plus brain scans for ongoing back pain

This trial studies a procedure called radiofrequency denervation to reduce long-lasting, mostly “pain-from-joints/structures” low back pain, and it uses brain imaging to understand what changes during treatment. It may help people who already showed they respond well to a similar diagnostic nerve block.

Aberdeen, Scotland
NCT06576128Recruiting
Numbing injection for pain relief during heart procedures

This study tests whether an ultrasound-guided numbing injection in the belly wall can reduce pain during heart procedures like angioplasty or stent placement. It is for people having planned (non-emergency) heart catheterization.

Istanbul
NCT07618156Not yet recruiting· Phase 1
Testing a new pain drug in healthy volunteers

This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.

Changsha, Hunan
NCT07618247Recruiting· Phase 1
Testing a new drug in healthy adults

This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.

Adelaide, South Australia
NCT05864053Recruiting· Phase 1/Phase 2
Ketamine medicine trial for chronic nerve pain in adults

This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.

Chicago, Illinois

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.